Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Preceptorship on Lung Cancer 2024: Rabat
- Start date
- 26 Jan 2024
- End date
- 27 Jan 2024
- Location
- Rabat, Morocco
Learning objectives
- To select the best treatment in a multidisciplinary approach for early stage Non-Small Cell Lung cancer (NSCLC)
- To identify molecular alterations driving the management of metastatic NSCLC
- To learn about the best strategy for metastatic NSCLC with targetable molecular alterations
- To learn about the best strategy for metastatic NSCLC eligible for immunotherapy
- To learn about the best strategy for SCLC
Accreditation
The programme of this event has been accredited with 11 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Mounir Bachouchi, Morocco
- Jaafar Bennouna, France
- Hassan Errihani, Morocco
- Céline Mascaux, France
Supported by
